Chest Area
|

EMPATICC-2 (AF+VT) - Cardiac Arrhythmias in Advanced Cancer

Institution: Department of Cardiology, Angiology and Intensive Care Medicine CBF, Deutsches Herzzentrum der Charité, Charité Universitätsmedizin Berlin
Applicant: Markus S. Anker, MD
Funding line:
Else Kröner Excellence Fellowships
EMPATICC-2 (AF+VT) - Evaluate and Monitor Patterns of ArrhyThmias In patients with advanced Cancer using event reCorders – 2 (Atrial Fibrillation & Ventricular Tachycardia)

People with advanced cancer have an increased risk of developing cardiac arrhythmias. These often remain undetected but could lead to serious complications, including stroke, hospitalization, or sudden cardiac death. However, little is known about how frequently these arrhythmias occur and how they affect survival and the course of the disease.

In the EMPATICC-2 research project, Dr. Markus Anker and his team investigate cardiac arrhythmias in patients with advanced cancer using small monitors implanted beneath the skin to continuously record heart rhythms. The devices are implanted only when clinically indicated, independently of study participation. The focus is on atrial fibrillation and potentially dangerous ventricular arrhythmias.

The aim is to detect cardiac arrhythmias earlier, better understand their prognostic significance, and ultimately improve cardiovascular care for people living with cancer.

Website working group cardio-oncology (AG Anker):

https://www.dhzc.charite.de/forschung/eintrag/ag-anker-189/